| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20015299 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20067886 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20015177 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20026584 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20016513 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS20030798 | HPV | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS44020094 | HTLV-1 | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
| TVIS44022969 | HTLV-1 | ENSG00000186350.12 | protein_coding | RXRA | No | No | 6256 | P19793 Q6P3U7 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | RXRA |
|---|---|
| DrugBank ID | DB00755 |
| Drug Name | Tretinoin |
| Target ID | BE0000412 |
| UniProt ID | P19793 |
| Regulation Type | agonist |
| PubMed IDs | 16946489; 9160172 |
| Citations | Mizuguchi Y, Wada A, Nakagawa K, Ito M, Okano T: Antitumoral activity of 13-demethyl or 13-substituted analogues of all-trans retinoic acid and 9-cis retinoic acid in the human myeloid leukemia cell line HL-60. Biol Pharm Bull. 2006 Sep;29(9):1803-9.@@Regazzi MB, Iacona I, Gervasutti C, Lazzarino M, Toma S: Clinical pharmacokinetics of tretinoin. Clin Pharmacokinet. 1997 May;32(5):382-402. doi: 10.2165/00003088-199732050-00004. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | |
| SMILES | CC(C=CC1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O |
| Pathways | Retinol Metabolism; Vitamin A Deficiency |
| PharmGKB | PA164746900 |
| ChEMBL | CHEMBL38 |
